Anatomic Pathology
...
Case Study using HALO™ and STRATA™: Biomarkers of Anti-Tumor Immune...
- Anatomic Pathology
- Clinical Laboratories
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- General Healthcare News
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Management & Operations
- Marketing
- Medical Research
- Pathology News
- Science
- Vendor products
- Web/Tech
- Webinars
- Whole slide
Wednesday September 28th | 8 AM PDT | 11 AM EDT | 4 PM BST Presenters Dr. Tricia Cottrell, Johns Hopkins Medical School Vlado Ovtcharov, Indica Labs PD-L1 expression in the tumor microenvironment can be both prognostic and predictive. ...
Optra Systems Wins Global Telepathology Enabling Technology Leaders...
OptraSCAN was recently recognized by Frost and Sullivan with a Global Telepathology Enabling Technology Leadership Award. And why shouldn't they be recognized -- I think they are hitting on one of the key market segments that is largely...
Inspirata Acquires Precision Medicine Network, Inc. and the ‘Crossw...
- Anatomic Pathology
- Business
- Clinical Laboratories
- Clinical Pathology
- Data Management
- Device Manufacturers
- Digital Pathology News
- Electronic Medical Records
- File format
- General Healthcare News
- Image Analysis
- Informatics
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- Marketing
- Medical Research
- Pathology News
- TeleHealth
- Vendor products
- Web/Tech
- Whole slide
“Crosswalk Insight™: Oncology” enhances Inspirata’s Digital Pathology Cockpit by providing access to Genomic Profiles, FDA-Approved Targeted Therapies, Immunotherapies and Clinical Trials to enable pathologists to make more precise...
Last Fall I wrote a couple of posts about the growing disenchantment with 'Pinkification' and 'Pinktober' referencing the all-out blitz during October to go "Pink" for breast bancer awareness and prevention. In one of the pieces I mentioned...
Science, health care and technology conglomerate Danaher Corp. DHR 0.28 % said Tuesday that it would buy molecular-diagnostics company Cepheid Inc. CPHD -0.20 % for $53.00 a share, in its first major acquisition since spinning off a...
